JPWO2022138787A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022138787A5
JPWO2022138787A5 JP2022571599A JP2022571599A JPWO2022138787A5 JP WO2022138787 A5 JPWO2022138787 A5 JP WO2022138787A5 JP 2022571599 A JP2022571599 A JP 2022571599A JP 2022571599 A JP2022571599 A JP 2022571599A JP WO2022138787 A5 JPWO2022138787 A5 JP WO2022138787A5
Authority
JP
Japan
Prior art keywords
oligonucleotide
pharmaceutical composition
guanine
cytosine
adenine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022571599A
Other languages
English (en)
Japanese (ja)
Other versions
JP7834290B2 (ja
JPWO2022138787A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/047754 external-priority patent/WO2022138787A1/ja
Publication of JPWO2022138787A1 publication Critical patent/JPWO2022138787A1/ja
Publication of JPWO2022138787A5 publication Critical patent/JPWO2022138787A5/ja
Application granted granted Critical
Publication of JP7834290B2 publication Critical patent/JP7834290B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022571599A 2020-12-22 2021-12-22 医薬組成物 Active JP7834290B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020213000 2020-12-22
JP2020213000 2020-12-22
PCT/JP2021/047754 WO2022138787A1 (ja) 2020-12-22 2021-12-22 医薬組成物

Publications (3)

Publication Number Publication Date
JPWO2022138787A1 JPWO2022138787A1 (https=) 2022-06-30
JPWO2022138787A5 true JPWO2022138787A5 (https=) 2025-01-07
JP7834290B2 JP7834290B2 (ja) 2026-03-24

Family

ID=82159838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022571599A Active JP7834290B2 (ja) 2020-12-22 2021-12-22 医薬組成物

Country Status (4)

Country Link
US (1) US20240052345A1 (https=)
EP (1) EP4268830A4 (https=)
JP (1) JP7834290B2 (https=)
WO (1) WO2022138787A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4117718A4 (en) * 2020-03-09 2024-05-08 University of Houston System INFLAMMATORY BOWEL DISEASE (IBD)-ASSOCIATED STEM CELLS, AGENTS TARGETING IBD-ASSOCIATED STEM CELLS AND RELATED USES THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617442B1 (en) 1999-09-30 2003-09-09 Isis Pharmaceuticals, Inc. Human Rnase H1 and oligonucleotide compositions thereof
WO2011097614A1 (en) * 2010-02-08 2011-08-11 Isis Pharmaceuticals, Inc. Mehods and compositions useful in diseases or conditions related to repeat expansion

Similar Documents

Publication Publication Date Title
JP7798836B2 (ja) Ｂ型肝炎感染の治療用のＰＡＰＤ５及びＰＡＰＤ７ ｍＲＮＡを低減させるための核酸分子
JP4383720B2 (ja) オリゴヌクレオチドｎ３’→ｐ５’ホスホルアミデート：合成および化合物；ハイブリダイゼーションおよびヌクレアーゼ耐性特性
US10421963B2 (en) Oligonucleotide therapy for leber congenital amaurosis
CA2817002C (en) Base modified oligonucleotides
JP2021507686A5 (https=)
CN107532162A (zh) 用于利用寡核苷酸编辑细胞中核酸的组合物和方法
JP2021505129A5 (https=)
CN104321334A (zh) 三环核苷及由其制备的低聚化合物
JPWO2022138787A5 (https=)
US20260062703A1 (en) Delivery of RNA Therapeutics Using Circular Prodrug Nucleic Acids
CN114829599A (zh) Scamp3抑制剂用于治疗乙型肝炎病毒感染的用途
JP2024542738A5 (https=)
WO2020038973A1 (en) Antisense oligonucleotides targeting sptlc1
CN118434860A (zh) 苏糖核酸反义寡核苷酸及其方法
CN119790155A (zh) 苏糖核酸反义寡核苷酸及其方法
JPWO2022250155A5 (https=)
CN114829601A (zh) Sbds抑制剂用于治疗乙型肝炎病毒感染的用途
US20250171820A1 (en) Method for producing oligonucleic acid
US20190367920A1 (en) Antisense oligonucleotides for modulating nfkb1 expression
Fatthalla et al. Improved DNA clamps by stacking to adjacent nucleobases
RU2024103826A (ru) Нуклеиновая кислота, композиция и конъюгат, содержащие ее, а также способ ее получения и применение
HK40109846A (zh) 减少papd5和papd7 mrna的核酸分子用於治疗乙型肝炎感染
HK40097454A (zh) 用於b型肝炎病毒感染的rnai剂
JP2024542728A5 (https=)
KR20250120380A (ko) 안티센스 RNA(asRNA) 기술 및 이의 용도